Correction to: Nature https://doi.org/10.1038/s41586-019-1195-2, published online 01 May 2019.
In the Acknowledgements section of this Article, the funding statement should have included that the work was supported in part by the Cure Alzheimer’s Fund (CAF). In addition, the final NIH grant acknowledged should have been ‘U01MH119509’ instead of ‘RF1AG054012’. In Supplementary Table 2, for the worksheets labelled ‘Ex’, ‘In’, ‘Ast’, ‘Oli’, ‘Opc’ and ‘Mic’, the column labels ‘early.pathology.mean’ and ‘late.pathology.mean’ were inadvertently reversed under the ‘early-pathology vs late-pathology differential expression’ heading (that is, columns Y and Z in each worksheet). These errors have been corrected online.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mathys, H., Davila-Velderrain, J., Peng, Z. et al. Author Correction: Single-cell transcriptomic analysis of Alzheimer’s disease. Nature 571, E1 (2019). https://doi.org/10.1038/s41586-019-1329-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-019-1329-6
This article is cited by
-
Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases
Nature Communications (2023)
-
Opposing effects of apoE2 and apoE4 on microglial activation and lipid metabolism in response to demyelination
Molecular Neurodegeneration (2022)
-
Illuminating Neural Circuits in Alzheimer’s Disease
Neuroscience Bulletin (2021)
-
Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
Molecular Neurodegeneration (2020)
-
Reconstruction of the human blood–brain barrier in vitro reveals a pathogenic mechanism of APOE4 in pericytes
Nature Medicine (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.